Drug profile · INN
pentetate calcium trisodium yb-169
YTTERBIUM YB 169 DTPA
pentetate calcium trisodium yb-169 (YTTERBIUM YB 169 DTPA) is a radioactive metals chelating agent. Route of administration: injection. Current US regulatory status: approved.
Drug details — pentetate calcium trisodium yb-169
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pentetate calcium trisodium yb-169 (YTTERBIUM YB 169 DTPA) is a radioactive metals chelating agent. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Radioactive metals chelating agent
Primary target: Radioactive metals
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pentetate calcium trisodium yb-169?
pentetate calcium trisodium yb-169 (YTTERBIUM YB 169 DTPA) is a radioactive metals chelating agent. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pentetate calcium trisodium yb-169?
YTTERBIUM YB 169 DTPA is a marketed brand name for pentetate calcium trisodium yb-169. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pentetate calcium trisodium yb-169?
pentetate calcium trisodium yb-169 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.